ClinicalTrials.gov
public full text
Public Domain
Open Label Extension Study of AMX0035 in Patients With ALS
This extension study, in which all participants received active treatment (AMX0035), was designed to assess the longer-term safety and therapeutic potential of AMX0035 for participants who have completed the Main Study (AMX3500, also known as CENTAUR).
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- A Clinical Trial to Learn About the Effects of VHB937 in People With Amyotrophic Lateral Sclerosis (ALS)#1032654
- A Substudy of LY4256984 in Participants With Sporadic Amyotrophic Lateral Sclerosis#1029891
- Clinical Trial of SB-509 in Subjects With Amyotrophic Lateral Sclerosis (ALS)#801481
- Digitized and AI-Assisted Scoring of Cognitive Assessments in ALS and Neurodegenerative Diseases: A Scoping Review of Consistency, Reliability, and Cross-Site Applicability#313294
- A Phase Ⅰ/Ⅱa Study of SNUG01 in Adult Subjects With ALS#841713
Record · ID 1085586
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive